The stem cell mobilizer stemenhance® does not promote tumor growth in an orthotopic model of human breast cancer

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 443-447

  Drapeau, Christian ^a   Ma, Huaiyu ^b   Yang, Zhijian ^b   Tang, Li ^b   Hoffman, Robert M ^b   Schaeffer, David J ^c  

^a STEMTech HealthSciences Inc   (United States)

^b ANTICANCER INC   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Bone marrow; Breast cancer; GFP; Nude mice; Stem cells

Indexed keywords

ANTIOXIDANT; STEM CELL MOBILIZER; STEMENHANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLUORESCENCE IMAGING; GROWTH RATE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL MOBILIZATION; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; BONE MARROW CELLS; BREAST NEOPLASMS; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MICE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 61449101797     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Correa P and Houghton J: Carcinogenesis of Helicobacter pylori. Gastroenterology 133: 659-672, 2007.
2. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
3. Houghton JM, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC: Gastric cancer originating from bone marrow-derived cells. Science 306: 1568-1571, 2004.
4. Hall B, Andreeff M and Marini F: The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted gene delivery vehicles. Handbook Exp Pharmacol 180: 263-283, 2007.
5. Aghi M and Chiocca EA: Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Molecular Therapy 12: 994-1005, 2005.
6. Cogle CR, Theise ND, Fu DT, Ucar D, Lee S, Guthrie SM, Lonergan J, Rybka W, Krause DS and Scott EW: Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells 25: 1881-1887, 2007.
7. Santarelli JG, Udani V, Yung YC, Cheshier S, Wagers A. Brekken RA, Weissman I and Tse V: Incorporation of bone-marrow derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain. Neurosurgery 59: 374-382, 2006.
8. Davidoff AM, Ng CY, Brown P, Leary MA, Spurbeck WW, Zhou J, Horwitz E, Vanin EF and Nienhuis AW: Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 7: 2870-2879, 2001.
9. Jensen GS, Hart AN, Zaske LA, Drapeau C, Gupta N, Schaeffer DJ and Cruickshank JA: Mobilization of human CD34+CD133+ and CD34+CD133-stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae - related to modulation of CXCR4 expression by an L-selectin ligand? Cardiovasc Revasc Med 8: 189-202, 2007.
10. Hoffman RM: Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 17: 343-359, 1999.
11. Hoffman RM: The multiple uses of fluorescent proteins to visualize cancer in vivo. Nature Rev Cancer 5: 796-806, 2005.
12. Hoffman RM and Yang M: Whole-body imaging with fluorescent proteins. Nature Protocols 1: 1429-1438, 2006.
13. Mardia K: Measures of multivariate skewness and kurtosis with applications. Biometrika 57: 519-530, 1970.
14. Henze N and Zirkler B: A class of invariant consistent tests for multivariate normality. Comm Stat: Theory Meth 19: 3595-3618, 1990.
15. Schaeffer DJ, Malpas PB and Barton LL: Risk assessment of microcystin in dietary Aphanizomenon flos-aquae. Ecotoxicol Env Safety 44: 73-80, 1999.
16. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg RA: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563, 2007.
17. Benedetti S, Benvenuti F, Pagliarani S, Francogli S, Scoglio S and Canestrari F: Antioxidant properties of a novel phycocyanin extract from the blue-green alga Aphanizomenon flos-aquae. Life Sci 75: 2353-2362, 2004.
18. Reddy CM, Bhat VB, Kiranmai G, Reddy MN, Reddanna P and Madyastha KM: Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis. Biochem Biophys Res Commun 277(3): 599-603, 2000.
19. Romay C, Ledon N and Gonzalez R: Phycocyanin extract reduces leukotriene B4 levels in arachidonic acid-induced mouse-ear inflammation test. J Pharm Pharmacol 51: 641-642, 1999.
20. Dainippon Ink & Chemicals and Tokyo Kenkyukai: Antitumoral agents containing phycobilin- also used to treat ulcers and hemorrhoidal bleeding. Patent #5865216, Japan, 1983.
21. Liu Y, Xu L, Cheng N, Lin L and Zhang C: Inhibitory effect of phycocyanin from Spirulina platensis on the growth of human leukemia K562 cells. J Appl Phycol 12: 125-130, 2000.
22. Jensen GS, Ginsberg DI, Huerta P, Citton M and Drapeau C: Consumption of Aphanizomenon flos-aquae has rapid effects on the circulation and function of immune cells in humans. J Am Nutraceut Assoc 2: 50-58 2000.